Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510),a novel A1-adenosine receptor agonist

This publication has 21 references indexed in Scilit:

• Electrophysiologic Effects of a Novel Selective Adenosine A1 Agonist (CVT-510) on Atrioventricular Nodal Conduction in Humans
  Journal of Cardiovascular Pharmacology and Therapeutics, 2001
• Role of A_2A‐adenosine receptor activation for ATP‐mediated coronary vasodilation in guinea‐pig isolated heart
  British Journal of Pharmacology, 2000
• A comparison of an A₁ adenosine receptor agonist (CVT‐510) with diltiazem for slowing of AV nodal conduction in guinea‐pig
  British Journal of Pharmacology, 1999
• Adenosine and Adenosine Receptors in the Cardiovascular System: Biochemistry, Physiology, and Pharmacology
  The American Journal of Cardiology, 1997
• Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes
  The FASEB Journal, 1995
• Effects of adenosine on atrial refractoriness and arrhythmias
  Cardiovascular Research, 1994
• Electrophysiological basis for the use of adenosine in the diagnosis and treatment of cardiac arrhythmias.
  Heart, 1990
• The cardiac effects of adenosine
  Progress in Cardiovascular Diseases, 1989
• Effect of adenosine on atrioventricular conduction. I: Site and characterization of adenosine action in the guinea pig atrioventricular node.
  Circulation Research, 1986
• Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias
  Journal of the American College of Cardiology, 1985